Effect of Care Package on Duration of Stay and Physiological Parameters in Non-invasive Mechanical Ventilation
The Effect Of The Care Package Applıed To Babıes Whıch Are Monıtored Wıth Temporary Follow-Up Of The Newborn In The Newborn Intensıve Care Unıt On The Duratıon Of Stay In Non-Invasıve Mechanıcal Ventılatıon And Physıologıcal Parameters
1 other identifier
interventional
80
1 country
1
Brief Summary
Temporary tachypnea of the newborn can be improved with minimal respiratory support and nursing care given to babies within the first 72 hours of life. Nursing care practices; It includes pain management, aspiration, moistening and warming of the airways, skin care, nutrition, body temperature regulation, positioning and chest physiotherapy practices. Physiotherapy practices, when applied in accordance with the criteria, can reduce the newborn's respiratory problems and shorten the hospital stay. Although it has been reported that chest physiotherapy practices have a clinically positive effect on newborns, studies in this field are insufficient. Nowadays, the concept of care package is frequently used, especially in areas where nursing care is very important, such as intensive care. Implementation of care packages in patient care increases the quality of care by ensuring standardization in the clinic. It also contributes to observing improvements in health practices. The positive results of the use of care packages in their application areas and the lack of care package application in babies monitored with temporary tachypnea of the newborn when the literature was scanned have led to the necessity of conducting studies in this field. The study was planned as a semi-experimental (non-randomized) control group study to examine the effect of the care package applied to babies monitored with temporary tachypnea of the newborn in the neonatal intensive care unit on the duration of stay in noninvasive mechanical ventilation and physiological parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedFirst Submitted
Initial submission to the registry
December 9, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Posted
Study publicly available on registry
January 5, 2024
CompletedJanuary 5, 2024
December 1, 2023
1.7 years
December 9, 2023
January 2, 2024
Conditions
Outcome Measures
Primary Outcomes (12)
Heart rate Vital Signs
Heart rate (beats/minute) were evaluated
It was evaluated upon admission to intensive care, 1 hour after the first care, and 1 hour after the first care after weaning from mechanical ventilation.
Respiratory Rate Vital Signs
Respiratory Rate (breaths/minute) were evaluated
It was evaluated upon admission to intensive care, 1 hour after the first care, and 1 hour after the first care after weaning from mechanical ventilation.
Body temperature Vital Signs
Body temperature (°C) were evaluated
It was evaluated upon admission to intensive care, 1 hour after the first care, and 1 hour after the first care after weaning from mechanical ventilation.
Oxygen saturation Vital Signs
Oxygen saturation (%) were evaluated
It was evaluated upon admission to intensive care, 1 hour after the first care, and 1 hour after the first care after weaning from mechanical ventilation.
Blood pressure Vital Signs
Blood pressure (mmHg) were evaluated
It was evaluated upon admission to intensive care, 1 hour after the first care, and 1 hour after the first care after weaning from mechanical ventilation.
blood gas pH value :
blood gas H iyon
It was evaluated upon admission to the intensive care unit, immediately before weaning from mechanical ventilation, and 1 hour after weaning from mechanical ventilation.
blood gas PCO2 value
blood gas PCO2 (mmHg) were evaluted
It was evaluated upon admission to the intensive care unit, immediately before weaning from mechanical ventilation, and 1 hour after weaning from mechanical ventilation.
blood gas HCO3 value
blood gas HCO3 (mEq/L) were evaluted
It was evaluated upon admission to the intensive care unit, immediately before weaning from mechanical ventilation, and 1 hour after weaning from mechanical ventilation.
blood gas PaO2 value
blood gas PaO2 (mmHg)were evaluted
It was evaluated upon admission to the intensive care unit, immediately before weaning from mechanical ventilation, and 1 hour after weaning from mechanical ventilation.
blood gas SaO2 value :
blood gas SaO2 (mmHg)were evaluted
It was evaluated upon admission to the intensive care unit, immediately before weaning from mechanical ventilation, and 1 hour after weaning from mechanical ventilation.
blood gas lactat value
blood gas lactat (mmol/L) were evaluted
It was evaluated upon admission to the intensive care unit, immediately before weaning from mechanical ventilation, and 1 hour after weaning from mechanical ventilation.
blood gas BE value
blood gas BE(mmol/L) were evaluted
It was evaluated upon admission to the intensive care unit, immediately before weaning from mechanical ventilation, and 1 hour after weaning from mechanical ventilation.
Secondary Outcomes (3)
Total duration of mechanical ventilation stay
1 hour after discharge from intensive care
Total duration of stay in intensive care unit duration of transition to oral feeding were evaluated).
1 hour after discharge from intensive care
Total duration of transition to oral feeding were
1 hour after discharge from intensive care
Study Arms (2)
Intervention Group
EXPERIMENTALIn addition to the clinical routine care, the newborn temporary tachypnea care package that we created was applied to the babies in the intervention group. Physiological parameters and blood gas results were recorded.
Control group
NO INTERVENTIONOnly clinical routine care practices were applied to the babies in the control group. Physiological parameters and blood gas results were recorded.
Interventions
Intervention Group: * Immediately after the newborn's admission to the intensive care unit, mechanical ventilation mode, physiological parameters, blood gas results and descriptive characteristics of the baby were recorded in the "Data Collection and Daily Monitoring Form". * In addition to the routine care practices of the clinic (every 3 hours / 8 times a day), the newborn's temporary tachypnea care package was applied. Postural drainage, percussion and vibration were applied 4 times a day for an average of 10-15 minutes. * Mechanical ventilation mode and physiological parameters were recorded one hour after 4 daily maintenance applications. * Blood gas parameters were evaluated immediately before and 1 hour after the newborn was separated from mechanical ventilation. * Physiological parameters were recorded again 1 hour after the first routine nursing care after the newborn was separated from mechanical ventilation.
Eligibility Criteria
You may qualify if:
- Being 36 weeks or above according to gestational age
- Birth weight being 1500 grams and above
- Receive noninvasive mechanical ventilation support
- Feeding via orogastric tube
- Parents' consent for the baby to be included in the study
You may not qualify if:
- Those with pneumothorax and suspicion
- Those with cranial bleeding or any suspicion of bleeding
- Babies with congenital anomalies affecting breathing
- Babies who are reconnected to mechanical ventilation after being weaned off noninvasive mechanical ventilation
- Babies with neurological diseases (no neurological problems (hypotonia, hypertonic etc.), no history of convulsions, not using sedative drugs, normal cranial USG,
- Babies with any fractures (clavicle, femur, etc.) were excluded from the sample.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Okan Universitylead
Study Sites (1)
Esma Şeker
Istanbul, 34230, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Gülzade Uysal, Assoc. Dr
Okan Üniversitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Esma Şeker
Study Record Dates
First Submitted
December 9, 2023
First Posted
January 5, 2024
Study Start
January 30, 2022
Primary Completion
October 30, 2023
Study Completion
December 31, 2023
Last Updated
January 5, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share